{
    "clinical_study": {
        "@rank": "139507", 
        "arm_group": [
            {
                "arm_group_label": "Mixed grain 1(Giant embryonic brown rice )", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Mexed grain 2 (Giant embryonic rice )", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "White rice", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Glucose solution", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This study was an open, 4-treatment, 5-sequence, 5-day cross-over randomized design clinical\n      trial to evaluate the efficacy of mixed grain on blood glucose, insulin and Glycemic\n      index(GI) in healthy males."
        }, 
        "brief_title": "The Effects of Mixed Grain on Blood Glucose and Insulin in Healthy Male", 
        "condition": [
            "Healthy People", 
            "Diabetes Mellitus, Type 2"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "detailed_description": {
            "textblock": "After a 12-hour fast, oral glucose or meal tolerance test was performed with blood samples\n      drawn at time 0, 15, 30, 45, 90, 120, 150, and 180 min.\n\n        1. Serum levels of glucose, insulin, and C-peptide were analyzed by biochemical\n           autoanalyzer. The area under the curve (AUC) changes in blood glucose were computed by\n           the trapezoidal method.\n\n        2. Glycemic index(GI): the area under the glucose response curve after consumption of a\n           test food divided by the area under the curve after consumption of a control food\n           containing the same amount of carbohydrate and calculated using 50 g glucose as the\n           reference."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Males, 19~60years old\n\n          -  Bodyweight was more than 50 kg with ideal body weight within \u00b130%\n\n          -  Less than 100 mg/dl in fasting blood glucose and less than 140 mg/dl in an oral\n             glucose tolerance test (OGTT)\n\n          -  Able to give informed consent\n\n        Exclusion Criteria:\n\n          -  Major medical illness such as cardiovascular, neurologic, psychiatric, renal,\n             pulmonary and hepatic diseases\n\n          -  History of disease that could interfere with the test products or impede their\n             absorption such as gastrointestinal disease or gastrointestinal surgery\n\n          -  Medical or psychological conditions deemed by the investigators to interfere with\n             successful participation in the study\n\n          -  Poor vital sign (systolic blood pressure: below 100 mmHg or above 150 mmHg, diastolic\n             blood pressure: below 65 mmHg or above95 mmHg)\n\n          -  Allergic or hypersensitive to any of the ingredients in the test products; treated\n             with any drug within past 2 weeks\n\n          -  Participation in any other clinical trials within past 2 months\n\n          -  Alcohol consumption above 21 units per week or abnormal screening laboratory test\n\n          -  Being judged by the responsible physician of the local study center as unfit to\n             participate in the study"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01840982", 
            "org_study_id": "CTCF2_2010_MC_2"
        }, 
        "intervention": [
            {
                "arm_group_label": "Mixed grain 1(Giant embryonic brown rice )", 
                "description": "All test foods contained 50 g available carbohydrate from the test food products. A glass of 200 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min.", 
                "intervention_name": "Mixed grain 1", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Mixed grain 1 (Giant embryonic brown rice) diet"
            }, 
            {
                "arm_group_label": "Mexed grain 2 (Giant embryonic rice )", 
                "description": "All test foods contained 50 g available carbohydrate from the test food products. A glass of 200 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min.", 
                "intervention_name": "Mixed grain 2", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Mixed grain 2 (Giant embryonic rice) diet"
            }, 
            {
                "arm_group_label": "White rice", 
                "description": "All test foods contained 50 g available carbohydrate from the test food products. A glass of 200 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min.", 
                "intervention_name": "White rice", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "control diet"
            }, 
            {
                "arm_group_label": "Glucose solution", 
                "description": "All test foods contained 50 g available carbohydrate from the test food products.", 
                "intervention_name": "Glucose solution", 
                "intervention_type": "Other", 
                "other_name": "Reference diet"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Mixed grains", 
            "Glycemic index", 
            "Giant embryonic brown rice", 
            "Giant embryonic rice", 
            "diabetes"
        ], 
        "lastchanged_date": "April 23, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Jeonju", 
                    "country": "Korea, Republic of", 
                    "state": "Jeollabuk-do", 
                    "zip": "560-822"
                }, 
                "name": "Clinical Trial Center for Functional Foods; Chonbuk National University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "4", 
        "official_title": "A Randomized, Crossover Clinical Trial, The Effects of Mixed Grain on Blood Glucose and Insulin in Healthy Male", 
        "overall_official": {
            "affiliation": "Chonbuk National University Hospital", 
            "last_name": "Soo-Wan Chae, MD., PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Glycemic index (GI) was defined as the area under the glucose response curve after consumption of a test food divided by the area under the curve after consumption of a control food containing the same amount of carbohydrate and calculated using 50 g glucose as the reference. Plasma glucose will be measured at baseline, 15, 30, 45, 60, 90, and 120 minutes post ingestion of each test solution.\nGI= (incremental blood glucose area of test meal/incremental area of glucose) \u00d7 100\nPlasma glucose and insulin will be measured at baseline, 15, 30, 45, 60, 90, 120, 180 and 240 minutes post ingestion of each test solution, and area under the curve will be calculated.\nPlasma c-peptide will be measured at baseline, 120 minutes post ingestion of each test solution.", 
            "measure": "1. Glycemic index(GI) 2. Glucose, insulin AUC(incremental area under the curve) 3. C-peptide", 
            "safety_issue": "Yes", 
            "time_frame": "2 hour postprandial blood glucose, insulin, c-peptide"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01840982"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chonbuk National University Hospital", 
            "investigator_full_name": "Soo-Wan Chae", 
            "investigator_title": "Director", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "HOMA-IR={fasting insulin(\u00b5U/\u3396) x fasting glucose(m\u33d6/L)}/22.5\nQUICKI=1/log(insulin 0min)-log(glucose 0min)\nIGI=(insulin 30min-fasting insulin)/(glucose 30min-fasting glucose)", 
            "measure": "Homeostatic model assessment-insulin resistance(HOMA-IR), quantitative insulin sensitivity check index(QUICKI), Insulinogenic index(IGI)", 
            "safety_issue": "Yes", 
            "time_frame": "fasting and postprandial (different times for 30min)"
        }, 
        "source": "Chonbuk National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chonbuk National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}